In other cancer categories, multiple studies have reported an association of upregulation of FMOD with poor patient survival in TCGA glioblastoma patients, and its product has been suggested to have an immunosuppressive role, whereas the silencing of FMOD leads to apoptosis in CCLE [150–152]. The gene discussed is FMOD; the disease is glioblastoma.